bladder cancer
Conditions
Interventions
A: Before the second cycle of induction intravesical chemotherapy, herbal medicine is applied as an acupoint plaster prior to the conventional intravesical instillation.
B:Induction chemotherapy following both the first and second TURBT consists of conventional intravesical instillation chemotherapy.
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with primary non-muscle-invasive bladder cancer according to the 2022 edition of the Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrology Diseases; 2.Age 18-80 years; 3. Patients who have undergone transurethral resection of bladder tumors; 4. Those requiring intravesical induction and maintenance therapy following transurethral resection of bladder tumors; 5. Those who voluntarily participate in this study and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Those unable to complete intravesical instillation therapy due to severe bladder instillation reactions; 2. Patients with skin diseases or allergic conditions that make them unsuitable for external drug application; 3.Those who alter the instillation medication during intravesical therapy; 4. Those receiving other treatments for bladder cancer (such as systemic chemotherapy) during intravesical therapy; 5. Those undergoing intravesical hyperthermic therapy; 6. Those with residual tumor or recurrence detected by imaging or cystoscopy within 8 weeks after bladder resection; 7. Other conditions deemed inappropriate for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Partial items from the EORTC QLQ-C30 questionnaire;Functional Assessment of Cancer Therapy – Bladder Cancer (FACT-BL); | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of days with dysuria and urinary frequency;Routine follow-up examinations during the follow-up period including imaging studies (such as ultrasound and CT) and cystoscopy.;Survival and recurrence rates;Adverse effects such as urinary frequency urgency dysuria and difficulty urinating; | — |
Countries
China
Contacts
Public ContactChenggen Jin
The Second Hospital of Hebei Medical University
Outcome results
None listed